Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Affiliations

• ¹ Barts Cancer Institute, Department of Medical Oncology, Queen Mary University of London and Royal Free London NHS Foundation Trust, London, UK.
• ² Université Paris Saclay, Institut Gustave Roussy, Villejuif, France.
• ³ Specialist Centre for Kidney Cancer, Royal Free London NHS Foundation Trust, London; Division of Surgery and Interventional Science, University College London, London, UK; Department of Urology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
• ⁴ Department of Pathology, Medical University of Vienna, General Hospital of Vienna, Vienna, Austria.
• ⁵ Interdisciplinary Genitourinary Oncology, West German Cancer Center Clinic for Internal Medicine and Clinic for Urology, University Hospital Essen, Essen, Germany.
• ⁶ Division of Medical Oncology, National Cancer Centre, Singapore, Singapore.
• ⁷ Department of Urology, Faculty of Medicine, University of Toyama, Toyama, Japan.
• ⁸ Department of Medicine and Urology, University of California San Diego, La Jolla, USA.
• ⁹ Interdisciplinary Department of Medicine, University of Bari 'A. Moro', Bari; Division of Medical Oncology, A.O.U. Consorziale Policlinico di Bari, Bari.
• ¹⁰ Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
• ¹¹ Department of Urology, Medical University of Vienna, Vienna, Austria.
• ¹² Medical Oncology, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
• ¹³ S. H. Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong SAR, China.
• ¹⁴ Instituto de Investigación i+12 and Departamento de Oncología Médica, Hospital University 12 de Octubre, Madrid, Spain.
• ¹⁵ Barts Cancer Institute, Department of Medical Oncology, Queen Mary University of London and Royal Free London NHS Foundation Trust, London, UK; Barts Cancer Institute, Department of Experimental Cancer Medicine, Queen Mary University of London, London, UK.
• ¹⁶ Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona; Università della Svizzera Italiana, Lugano, Switzerland.